Overall, we identified a novel OPTN frameshift insertion in a family with frontotemporal dementia and parkinsonism/CBS but without clinical and neurophysiological evidence of ALS, expanding the phenotypic spectrum of OPTN mutations. This evidence concerns the gene OPTN and Parkinson disease.